Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine

NCT02366013 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

NETWORK

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: rcAd26.MOS1.HIV-Env 1x10^8 vp
BIOLOGICAL: rcAd26.MOS1.HIV-Env 1x10^9 vp
BIOLOGICAL: rcAd26.MOS1.HIV-Env 1x10^10 vp
BIOLOGICAL: rcAd26.MOS1.HIV-Env 1x10^11 vp

Sponsor

International AIDS Vaccine Initiative

Collaborators

[object Object]
[object Object]